© 2025 swii.ch health
Exploring the ideas, innovations, and individuals shaping the future of rare disease.
As EU HTA evolves under the Joint Clinical Assessment (JCA), the expectations for structured, regulator-ready patient engagement[…]
The bar for patient evidence in EU health technology assessment (HTA) is rising fast. As the Joint Clinical[…]